Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
07/22/2008 | US7402558 Improved embyros implanting; prenancy |
07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
07/22/2008 | CA2458932C Methylene-4-azasteroids |
07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
07/22/2008 | CA2248841C Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
07/17/2008 | WO2008084717A1 Tricyclic compound and pharmaceutical use thereof |
07/17/2008 | WO2007062483A8 Increasing pregnancy rates |
07/17/2008 | US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation |
07/17/2008 | US20080171700 Use Of Secretagogue For The Teatment Of Ghrelin Deficiency |
07/17/2008 | US20080171692 Substituted amides |
07/17/2008 | DE202007003266U1 Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen Pharmaceutical composition for protection against allergies and inflammatory diseases |
07/17/2008 | CA2674045A1 Tricyclic compound and pharmaceutical use thereof |
07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
07/16/2008 | EP1944041A1 Therapeutic agent for neurogenic pain |
07/16/2008 | EP1944021A1 Equol level regulator |
07/16/2008 | EP1942921A2 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
07/16/2008 | EP1446104B1 Spray drying methods |
07/16/2008 | EP1386913B1 Pyrrole derivative |
07/16/2008 | EP1286966B1 4-aminopiperidine derivatives and their use as medicine |
07/16/2008 | EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor |
07/16/2008 | CN101223135A Preparation of paricalcitol and crystalline forms thereof |
07/16/2008 | CN101219210A Agent kit containing oral insulin solid therapy |
07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
07/16/2008 | CN100402087C Lyophilized suspended powder injection and preparation method thereof |
07/16/2008 | CN100401912C Slowly digestable starch product |
07/15/2008 | US7399867 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-3,4-dihydro-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine for therapy of endometriosis and/or uterine leiomyoma/leiomyomata |
07/15/2008 | US7399829 Variants of RANKL protein |
07/10/2008 | WO2008021422A3 Process for the preparation of indolin-2-one derivatives useful as pr modulators |
07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
07/10/2008 | US20080167356 metabolic syndrome, diabetes, cholestatic liver disease, fibrosis; improved glucose tolerance and decreased insulin resistance; 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid |
07/10/2008 | US20080167283 Nandrolone 17 Beta-Carbonates |
07/10/2008 | US20080167282 Particularly androgens, for the treatment of disorders resulting from use, especially abuse, of substances including intoxication, withdrawl, addiction, mental disorders, gambling, or recurrent criminal behavior. |
07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
07/09/2008 | EP1940863A2 Nitrooxy derivatives op glucocorticoids |
07/09/2008 | EP1940837A2 Imidazopyridine compounds |
07/09/2008 | EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
07/09/2008 | EP1446144B1 The use of leptin in infertility |
07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
07/09/2008 | CN101218245A 3-ester prodrugs of ethynylestradiol |
07/09/2008 | CN101217964A Method for preparing and using water-based steroid pheromone compositions |
07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
07/09/2008 | CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
07/08/2008 | US7396920 Tumour suppressor and uses thereof |
07/08/2008 | US7396859 Perturbed membrane-binding compounds |
07/08/2008 | US7396809 Methods and reagents for treating glucose metabolic disorders |
07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
07/08/2008 | CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
07/08/2008 | CA2384184C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
07/03/2008 | WO2008078730A1 Preparation for transnasal application |
07/03/2008 | WO2008078725A1 Thiazepine derivative |
07/03/2008 | WO2008077646A1 Non-steroidal progesterone receptor modulators |
07/03/2008 | WO2008034796A3 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
07/03/2008 | WO2008033304A3 Compositions for promoting non-leaky collateral vascularization |
07/03/2008 | WO2008027854A3 Pharmaceutical compositions comprising hgh for oral delivery |
07/03/2008 | WO2007070355A3 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
07/03/2008 | US20080161354 Stable s-nitrosothiols, method of synthesis and use |
07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
07/03/2008 | US20080161244 Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes |
07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
07/03/2008 | US20080160033 Novel Screening Method |
07/03/2008 | CA2673657A1 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
07/02/2008 | EP1939194A1 Bicyclic aromatic substituted pyridone derivative |
07/02/2008 | EP1938819A2 Use of specific cyclolignans |
07/02/2008 | EP1938818A2 Use of specific cyclolignans |
07/02/2008 | EP1938810A1 Ameliorating agent for metabolic syndrome |
07/02/2008 | EP1667521A4 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
07/02/2008 | EP1496838A4 Substituted amides |
07/02/2008 | EP1250148B2 Use of fsh for treating infertility |
07/02/2008 | CN101212973A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
07/02/2008 | CN101212972A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
07/02/2008 | CN101212971A 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility |
07/02/2008 | CN101209075A Health care tea for female |
07/02/2008 | CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
07/01/2008 | US7393861 Derivatives of 4-aminopiperidine and their use as a medicament |
07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
07/01/2008 | US7393543 Vaginally administratable progesterone-containing tablets and method for preparing same |
06/26/2008 | WO2008075162A2 Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction |
06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
06/26/2008 | WO2008074097A1 Pharmaceutical compound and composition |
06/26/2008 | WO2008002490A3 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
06/26/2008 | US20080153899 Fatty amine drug conjugates |
06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |
06/26/2008 | US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma, |
06/26/2008 | US20080152699 Method of treating menopausal women transdermally with testosterone |
06/26/2008 | DE102006061913A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula |
06/26/2008 | CA2673418A1 Pharmaceutical compound and composition |
06/25/2008 | EP1935423A2 Composition for treating and/or prophylaxis of tumors of the breast |